1. Dynamics of hepatitis B virus quasispecies heterogeneity and virologic response in patients receiving low‐to‐moderate genetic barrier nucleoside analogs. Issue 4 (15th November 2012) Authors: Peveling‐Oberhag, J.; Herrmann, E.; Kronenberger, B.; Farnik, H.; Susser, S.; Sarrazin, C.; Zeuzem, S.; Hofmann, W.‐P. Journal: Journal of viral hepatitis Issue: Volume 20:Issue 4(2013) Page Start: 234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus. Issue 4 (2nd September 2014) Authors: Dultz, G.; Gerber, L.; Farnik, H.; Berger, A.; Vermehren, J.; Pleli, T.; Zeuzem, S.; Piiper, A.; Kronenberger, B.; Waidmann, O. Journal: Journal of viral hepatitis Issue: Volume 22:Issue 4(2015) Page Start: 427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The impact of antihyperlipidemic drugs on the viral load of patients with chronic hepatitis C infection: a meta‐analysis. Issue 8 (18th June 2014) Authors: Grammatikos, G.; Farnik, H.; Bon, D.; Böhlig, A.; Bader, T.; Berg, T.; Zeuzem, S.; Herrmann, E. Journal: Journal of viral hepatitis Issue: Volume 21:Issue 8(2014) Page Start: 533 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗